|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 35/15 | (2015.01) |
| A61K 35/15 | (2013.01) | ||
| A61K 39/00 | (2006.01) | ||
| A61K2039/5156 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61K2039/5158 | (2013.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61K 38/177 | (2013.01) | ||
| A61K 39/001126 | (2018.08) |
| (11) | Patento numeris | 3895712 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 21160170.3 |
| Europos patento paraiškos padavimo data | 2017-12-11 | |
| (97) | Europos patento paraiškos paskelbimo data | 2021-10-20 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2022-06-22 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 201662432302 P | 2016-12-09 | US |
| (72) |
O'DWYER, Michael Eamon Peter , IE
|
| (73) |
ONK Therapeutics Limited ,
C/O Coll & Company
Pier Road
Barna Village, Co. Galway H91 V6KV,
IE
|
| (54) | ENGINEERED NATURAL KILLER CELLS AND USES THEREOF |
| ENGINEERED NATURAL KILLER CELLS AND USES THEREOF |